 |
|
|
Thomas RaffinAcademic Appointments
Appointment
Organization
Emeritus (Active) Professor
|
Curriculum Vitae Doc
Honors & Awards
Title
Organization
Date(s)
Henry J. Kaiser Foundation Award for Excellence in Preclinical Teaching
Stanford University Medical School
1997
Henry J. Kaiser Award for Excellence in Clinical Teaching
Stanford University Medical School
1988
Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching
Stanford University Medical School
1984
Arthur L. Bloomfield Award for Excellence in the Teaching of Clinical Medicine
Stanford University Medical School
1981
Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching
Stanford University Medical School
1980
Administrative Appointments
Title
Organization
Start Year
End Year
Course Founder and Director - Ethical Values in Health Care: Lessons from the Nazi Period
Stanford University Undergraduate Curriculum
1994
1996
Course Founder and Director - Intensive Life Support Systems: Present Practice and Moral Issues
Stanford University Undergraduate Curriculum
1984
1988
Co-Founder and Co-Director
Stanford Program in Genomics, Ethics and Society
1995
-
Co-Founder
Hutchison Program in Translational Medicine at Stanford University($5,000,000)
1998
2003
Consultant
Nektar, Inc.
1999
-
10 appointments: view full list
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
Fellow
Stanford Medical School
Pulmonary and Critical Care
1978
Resident
Peter Bent Brigham Hospital
Internal Medicine
1975
MD
Stanford School of Medicine
Medicine
1973
AB
Stanford University
Biological Sciences
1968
Web Site Links
Research/Lab website:
Stanford Center for Biomedical Ethics
Research Interests
Acute lung tissue injury is often mediated by neutrophils. Our laboratory studied the basic biology of neutrophils and mechanisms of neutrophil-mediated pulmonary injury. Investigative approaches included the molecular biology of neutrophil activation, neutrophil ion channel regulation, mechanisms of signal transduction with an emphasis on protein phosphorylation, control of neutrophil activation and the use of animal models to investigate the use of agents and intermediaries which might attenuate neutrophil-mediated acute lung injury. Besides these areas of basic investigation, clinical studies in biomedical ethics were also pursued. For example: End-of-life decision making, differences in informed consent and decision making between patients and physicians in Japan and America, the efficacy of ethics committees in the United States, the new role of biomedical ethics in managed care; social, ethical and legal issues in genomics and genetic testing, and neuroethics.
Community and International Work
- Stanford University-Asia Medical Fund, Stanford University More »
Publications
- Illes J, Kann D, Karetsky K, Letourneau P, Raffin TA, Schraedley-Desmond P, Koenig BA, Atlas SW "Advertising, patient decision making, and self-referral for computed tomographic and magnetic resonance imaging." Arch Intern Med 2004 Dec 13-27; 164: 22: 2415-9 More »
- Ziedalski TM, Raffin TA, Sze DY, Mitchell JD, Robbins RC, Theodore J, Faul JL "Chylothorax after heart/lung transplantation." J Heart Lung Transplant 2004; 23: 5: 627-31 More »
- Illes J, Rosen AC, Huang L, Goldstein RA, Raffin TA, Swan G, Atlas SW "Ethical consideration of incidental findings on adult brain MRI in research." Neurology 2004; 62: 6: 888-90 More »
- Illes J, Kirschen MP, Karetsky K, Kelly M, Saha A, Desmond JE, Raffin TA, Glover GH, Atlas SW "Discovery and disclosure of incidental findings in neuroimaging research." J Magn Reson Imaging 2004; 20: 5: 743-7 More »
- Davis KK, Berry GJ, Raffin TA, Faul JL "Thoracic lymphatic disorders." Lymphat Res Biol 2004; 2: 3: 131-7 More »
98 publications: view full list
Internal Staff Login